Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smaller version of Cypher DES approved by FDA

This article was originally published in Clinica

Executive Summary

The US FDA has approved a smaller version of Cypher, Cordis's sirolimus-eluting stent. The new 2.25mm device is indicated for treatment of coronary blockages in small vessels. In recent months, the agency has approved two other drug-eluting stents (DESs) for the treatment of small vessel disease: Boston Scientific's Taxus Liberté Atom and Taxus Express Atom, both of which elute paclitaxel. Cypher is widely regarded as safer than the Taxus family of devices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044341

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel